Wave Life Sciences, Inc. WVE
Set alert
3.58 USD +0.06 +1.70%
As of Nov 3, 11:36 AM ET
3.55 Day range 3.67
3.04 52-week range 21.73
- YTD
- -78.94%
- 1 year
- -56.92%
- Open
- 3.55
- Prev close
- 3.52
- Mkt cap
- 706.08M
- Vol
- 726.04K
- Avg vol
- 3.28M
- EPS
- -1.07
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.55
- High
- 3.67
- Forward P/E
- -4.33
- Beta
- -1.29
- Short ratio
- 5.75
- Inst. own
- 85.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 5.77
- 200-d avg
- 9.39
- 1y target
- 19.06
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 19.06 +432.5% upside
Now 3.58
- Target (low)
- 12.00
- Target (mean)
- 19.06
- Target (high)
- 42.00
Ratings (0m) 16 16 buy · 0 hold · 0 sell
- Strong buy2
- Buy14
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 16
- 1 month ago 16
- 2 months ago 16
- 3 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.31703 | -0.36 – -0.25 | -0.32 | +0.9% | 4.88M | -35.9% | 13 |
| Next quarter | -0.3308 | -0.42 – -0.24 | -0.30 | -10.3% | 5.98M | -65.3% | 12 |
| Current year | -1.11 | -1.22 – -0.87 | -1.21 | +8.3% | 52.28M | +22.4% | 12 |
| Next year | -1.19 | -1.68 – -0.07 | -1.11 | -7.3% | 37.00M | -29.2% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 4, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 31, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 31, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Jul 31, 2026 | Wedbush | Maintained | Outperform | Outperform |
| May 20, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 19, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 4, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 30, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 29, 2026 | Truist Securities | Maintained | Buy | Buy |
| Apr 14, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 27, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 27, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 25, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 6, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Mar 2, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 5, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Feb 3, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 19, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 16, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Dec 15, 2025 | Truist Securities | Maintained | Buy | Buy |
| Dec 12, 2025 | B. Riley Securities | Maintained | Buy | Buy |
| Dec 12, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Dec 9, 2025 | Citigroup | Maintained | Buy | Buy |
| Dec 9, 2025 | Canaccord Genuity | Maintained | Buy | Buy |
| Dec 9, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Dec 9, 2025 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Dec 9, 2025 | Clear Street | Maintained | Buy | Buy |
| Dec 9, 2025 | RBC Capital | Upgrade | Sector Perform | Outperform |